Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-048379
Filing Date
2018-09-06
Accepted
2018-09-06 21:17:59
Documents
2
Period of Report
2018-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 tv501539_form3.html 3  
1 FORM 3 tv501539_form3.xml 3 1547
2 EXHIBIT 24.1 tv501539_ex24-1.htm EX-24.1 11876
  Complete submission text file 0001144204-18-048379.txt   15013
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21 TEANECK NJ 07666
Business Address
BENDHEIM Jonathan (Reporting) CIK: 0001751891 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36410 | Film No.: 181058782